Aditxt, Inc.
Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.
ADTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0070251097
- LEI:
- Country:
- United States of America
- Address:
- 737 N. FIFTH STREET, SUITE 200, 23219 RICHMOND
- Website:
- https://aditxt.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Aditxt, Inc. is a biotechnology innovation company focused on discovering, developing, and deploying technologies to address significant health challenges. The company's business model centers on acquiring innovative and scalable life sciences companies and leveraging its business acceleration platform to drive growth and market penetration. Aditxt's portfolio includes programs targeting autoimmunity (Adimune), early cancer detection (Pearsanta), and neurological diagnostics (Adivue), with planned acquisitions in areas like reproductive health. The company aims to monetize these assets through strategic options such as mergers, sales, licenses, or IPOs to foster long-term growth.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aditxt, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aditxt, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aditxt, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
